| Subject: | FDA and Actavis Totowa LLC Announce Voluntary Recall of All Drug Products Manufactured in Little Falls, NJ Facility |
| Category: | Food and Drug Administration (FDA)
|
| Published: | Tue, 5 Aug 2008 - 09:00 am |
| The Food and Drug Administration (FDA) and Actavis Totowa LLC, a generic drug manufacturer, has announced a voluntary recall, to the retail level, of all drug products manufactured at Actavis’ Little Falls, New Jersey facility. This is a precautionary, voluntary action by Actavis following an inspection conducted by the Food and Drug Administration earlier this year which revealed operations that did not meet the FDA's or Actavis' standards for good manufacturing practices. ... The full article is available to StayAlert subscribers. Click here for a free trial subscription. |
|
RESOURCES:
External Links:
|
|
StayAlert! notifies healthcare customers of all federal and regulatory body legislation changes impacting the healthcare industry, including TJC (JCAHO), CDC, CMS, DHHS, FDA, OSHA, OIG and many others. StayAlert! complements this with regulatory implementation action plans. StayAlert! serves as a virtual healthcare department, augmenting traditional employee staffed departments and freeing employees to perform other vital functions. Currently StayAlert! is the leader in the comprehensive compliance information marketplace. Why? Because StayAlert! provides healthcare professionals with more than information. StayAlert! provides a service, in many cases "doing the work" for you, and assisting regulatory compliance officers to effectively and efficiently meet changing standards. |
|
